Apollomics Warrant Stock Fundamentals
| APLMW Stock | 0.03 0.00 0.00% |
Apollomics Warrant fundamentals help investors to digest information that contributes to Apollomics Warrant's financial success or failures. It also enables traders to predict the movement of Apollomics Stock. The fundamental analysis module provides a way to measure Apollomics Warrant's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apollomics Warrant stock.
At this time, Apollomics Warrant's Tax Provision is fairly stable compared to the past year. Net Interest Income is likely to climb to about 728.1 K in 2025, whereas Depreciation And Amortization is likely to drop slightly above 758.7 K in 2025. Apollomics | Select Account or Indicator |
Apollomics Warrant Company EBITDA Analysis
Apollomics Warrant's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Apollomics Warrant EBITDA | (171.75 M) |
Most of Apollomics Warrant's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apollomics Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Apollomics Ebitda
According to the company disclosure, Apollomics Warrant reported earnings before interest,tax, depreciation and amortization of (171.75 Million). This is 119.57% lower than that of the Biotechnology sector and 271.48% lower than that of the Health Care industry. The ebitda for all United States stocks is 104.41% higher than that of the company.
Apollomics Warrant Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apollomics Warrant's current stock value. Our valuation model uses many indicators to compare Apollomics Warrant value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apollomics Warrant competition to find correlations between indicators driving Apollomics Warrant's intrinsic value. More Info.Apollomics Warrant is rated fifth in current valuation category among its peers. It is rated below average in number of shares shorted category among its peers . The ratio of Current Valuation to Number Of Shares Shorted for Apollomics Warrant is about 29,304 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Apollomics Warrant by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Apollomics EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollomics Warrant's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollomics Warrant could also be used in its relative valuation, which is a method of valuing Apollomics Warrant by comparing valuation metrics of similar companies.Apollomics Warrant is currently under evaluation in ebitda category among its peers.
Apollomics Fundamentals
| Current Valuation | 20.54 M | ||||
| Number Of Shares Shorted | 701 | ||||
| Price To Book | 0.04 X | ||||
| Revenue | 821 K | ||||
| EBITDA | (171.75 M) | ||||
| Net Income | (172.59 M) | ||||
| Total Debt | 4.66 M | ||||
| Cash Flow From Operations | (43.21 M) | ||||
| Number Of Employees | 59 | ||||
| Market Capitalization | 31.5 M | ||||
| Total Asset | 55.39 M | ||||
| Retained Earnings | (646.97 M) | ||||
| Working Capital | 26.37 M | ||||
| Net Asset | 55.39 M |
About Apollomics Warrant Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollomics Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollomics Warrant using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollomics Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 738.9 K | 596.8 K | |
| Cost Of Revenue | 798.1 K | 758.7 K | |
| Stock Based Compensation To Revenue | 13.91 | 7.73 | |
| Sales General And Administrative To Revenue | 28.91 | 27.47 | |
| Research And Ddevelopement To Revenue | 37.48 | 44.94 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 0.01 | 0.01 | |
| Ebit Per Revenue | (60.11) | (63.12) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Apollomics Stock Analysis
When running Apollomics Warrant's price analysis, check to measure Apollomics Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apollomics Warrant is operating at the current time. Most of Apollomics Warrant's value examination focuses on studying past and present price action to predict the probability of Apollomics Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apollomics Warrant's price. Additionally, you may evaluate how the addition of Apollomics Warrant to your portfolios can decrease your overall portfolio volatility.